MedTrace Logo

Combining Antidepressant Medication and Psychotherapy for Insomnia to Improve Depression Outcome

NCT00149825 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2014-05-20

Study results available
· View outcomes & findings →

Summary

This study will examine the effectiveness of a combination of antidepressant medication and sleep-focused psychotherapy to simultaneously treat sleep difficulties and depression.

Conditions

Interventions

DRUG

Escitalopram

5 to 20 mg for 12 weeks

BEHAVIORAL

CBTI

Cognitive Behavioral Treatment for Insomnia

BEHAVIORAL

CTRL

Control Therapy consists of Pseudo-desensitization Therapy for Insomnia

Sponsors & Collaborators

Principal Investigators

  • Rachel Manber, PhD · Stanford University Medical School, Department of Psychiatry and Behavioral Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-06-30
Primary Completion
2007-08-31
Completion
2007-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00149825 on ClinicalTrials.gov